Status:
COMPLETED
Montelukast in Pediatric Allergic Asthma (0476-336)(COMPLETED)
Lead Sponsor:
Organon and Co
Conditions:
Asthma
Eligibility:
All Genders
6-14 years
Phase:
PHASE3
Brief Summary
This is a 3-week study to evaluate FEV1 following treatment with drugs in persistent asthma which is also active during allergy seasons in pediatric patients with seasonal aeroallergen sensitivity.
Eligibility Criteria
Inclusion
- Male and female patients, ages 6 to 14 years, with persistent asthma that is also active during allergy season
- Patients must demonstrate positive skin prick tests to seasonally relevant geographic aeroallergens
Exclusion
- Patient cannot have any other acute or chronic pulmonary disorder
Key Trial Info
Start Date :
March 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2007
Estimated Enrollment :
421 Patients enrolled
Trial Details
Trial ID
NCT00289874
Start Date
March 1 2006
End Date
July 1 2007
Last Update
February 2 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.